In the treatment of rhesus hemolytic disease, blood transfusion of babies still in utero has become established for the removäl of life ' 'threatening anemia. In Hamburg-Eppendorf, prenatal blood substitutions have been carried out since 1966 and, so far, 252 transfusions in 130 fetuses have been successful. The success rate amounts to 53%. If one excludes the children who at the time of their first transfusion already showed ascites and hence were treated too late, then among 91 transfused children 56 (61.5%) survived. As prenatal transfusions carry a risk, especially for the fetus, we should attempt to answer the following questions: Up to now, 39 babies, whose ascites was aspirated at the time of their first transfusion, have received äs many äs 4 transfusions (Fig. 1) . The earliest successful transfusion was in the 24th week. 13 children survived. The amount of ascites ranged from l to 200 mls. It was rarely possible to remove enough of the ascites to prevent dilution of the transfused blood in the babies' abdomen. According to our observations, the amount of ascites aspirated at the first transfusion correlates with the prognosis (Tab. I). The prospects of producing a living and healthy baby is much larger when the amount of ascites is under 5 mls than when it is greater than 5 mls. In these two cases, death must be attributed to the technical procedure. The risk, in our experience, therefore comprises about 6%.
Curriculum vitae
Summary Prenatal blood transfusion of a fetus established anemia due to rhesus hemolytic disease can be life saving. In Hamburg-Eppendorf 252 transfusions in 130 babies have so far been carried out. The success rate was 51%. Out of 39 babies who had ascites at the time of the first transfusion, 13 survived. The amount of ascites aspirated at the first transfusion correlates with the prognosis: The chance of producing a living and healthy child is greater when the amount of ascites is under 5 mls than when it is over 5 mls. Babies with amniotic fluid bilirubin values from 0.4 to 0.6 still have a good chance of survival, whereas the prospects of success with values over 0.6 are very small. The technical risk of prenatal transfusion before the 27th week amounts, according to our observations, to about 6%.
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